Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Botulinum Toxin A (BOTOX®) on Headache Attributed to TMD - An Open Label Trial

NCT03346252 is registered in ClinicalTrials.gov with State University of New York at Buffalo as lead sponsor.

NCT NCT03346252
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03346252 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Botulinum Toxin A (BOTOX®) on Headache Attributed to TMD - An Open Label Trial
Lead sponsor
State University of New York at Buffalo
Phase
Phase 1
Overall status
Completed
Start date
May 8, 2017
Completion date
March 15, 2021
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

secondary headache disorder